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 A birthday invitation
With the publication of this month’s issue, we mark 
The Lancet Global Health’s ﬁ rst birthday. I hope you will 
allow me to eﬀ use for a moment in the manner of a 
new parent discovering the fascination of her oﬀ spring’s 
everyday achievements… 
Since its conception in March, 2013, the infant TLGH 
has maintained a healthy intake of submissions, with an 
average of 72 per month and a total of more than 1000 to 
date. Its diet has been varied, ranging from noma in Niger 
to sexual violence in Asia-Paciﬁ c, with this nutritious 
fodder being sourced from a total of 79 countries (luckily 
air miles were saved by cunning use of online delivery 
vehicles).
Baby TLGH hit all of its developmental milestones, 
having published 52 original research articles, 
101 commentaries, and 61 letters to the editor in its 
ﬁ rst 12 months. Additionally, in a display of astonish-
ing (to its parent) precociousness, its conjoined twin, 
The Lancet Global Health Blog, published 50 posts—all 
bar four of which were spontaneously submitted.
Finally, if you’ll permit me to labour a metaphor for one 
more paragraph, because TLGH’s progress can be followed 
without the need to pay to join an exclusive community 
(ie, to buy a subscription), family (researchers), friends 
(readers), and wellwishers (everyone else) have been 
generous in their support: the journal has more than 
6000 Twitter followers and almost 30 000 individuals 
signed up for new content alerts, and saw nearly 183 500 
full-text downloads over the past year. I am tremendously 
grateful for the conﬁ dence shown in the journal so far 
and am excited to join TLGH’s supporters in anticipating 
the coming years of publishing inﬂ uential research and 
thought-provoking commentary.
But to concentrate on this month’s issue for a while, 
the Comment section sees a ﬂ urry of post-2015 attention 
as stakeholders gear up for the UN General Assembly 
in September. This year’s meeting is a critical milestone 
in the process of development planning for the period 
beyond the Millennium Development Goals’ (MDGs) 
expiry in 2015. Agency actors are seeking to combine 
the two current development tracks: the Sustainable 
Development Goal (SDG) process that was born of the 
Rio+20 earth summit in 2012 and the various post-MDG 
consultations led by UN Secretary General Ban Ki-Moon 
since late 2011. After the meeting, Ban will put together 
a synthesis report that amalgamates the inputs for both 
tracks and sets out a new framework for development 
after 2015.
This new framework will inevitably include a set of 
new targets for the next 15–20 years, and several have 
been put forward already: that all countries achieve a 
neonatal mortality ratio of no more than 12 per 1000 
livebirths by 2030 (or 10 by 2035); an under-5 mortality 
ratio of no more than 25 per 1000 livebirths by 2030 
(or 20 by 2035); and a maternal mortality ratio of 
fewer than 70 per 100 000 livebirths by 2030 (or 50 by 
2035). In their Comment in this issue, Robert Cohen and 
colleagues explore how feasible these targets would 
be for countries, particularly those in sub-Saharan 
Africa. One criticism of the MDGs was that ﬁ xed targets 
inevitably lead to a sense of futility or of failure for 
countries whose chances of achieving them are virtually 
nil. Cohen and colleagues suggest supplementing global 
goals with country-speciﬁ c ones, and indeed this is not 
the ﬁ rst call for such targets. The Task Team for the 
Global Thematic Consultation on Health concluded that 
“Countries should set targets according to what they 
can achieve in their own settings and with the resources 
available to them intrinsically, rather than solely through 
development assistance.”
Empowering local decision makers to calculate what 
is feasible and cost-eﬀ ective in that country is a crucial 
component of sustainable development, and Mark Jit 
and colleagues’ Article describes one potential means to 
achieve such agency as it applies to human papillomavirus 
(HPV) vaccination. Jit and colleagues construct a user-
friendly model that uses simpliﬁ ed inputs to calculate the 
health and economic beneﬁ ts of HPV vaccination of girls 
before sexual debut. The model performed comparably 
with established, more complex, cost-eﬀ ectiveness 
models and showed that HPV vaccination of girls is likely 
to be cost-eﬀ ective in almost every country.
Agency—the capacity for human beings to make 
choices—should be at the heart of any global health 
agenda. As The Lancet Global Health continues on its 
developmental journey, we invite original research 
whose aim is not merely to inform, but to empower.
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